US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Novartis AG

158.86

+2.621.68%

Post-market: 160.001.14+0.72%19:41 EDT

Volume:1.18M

Turnover:187.89M

Market Cap:303.10B

PE:24.02

High:159.72

Open:156.17

Low:156.10

Close:156.24

52wk High:170.46

52wk Low:121.57

Shares:1.91B

Float Shares:1.85B

Volume Ratio:0.73

T/O Rate:0.06%

Dividend:4.67

Dividend Rate:2.94%

EPS(TTM):6.61

EPS(LYR):7.15

ROE:30.35%

ROA:10.25%

PB:7.30

PE(LYR):22.22

Loading ...

Overview Company News Filings

Bank of America Securities Remains a Buy on Novartis (NVS)

Novartis announces biomarker cohort in study of del-brax met primary endpoint

Novartis Says Early-to-Mid Stage Study for Muscular Dystrophy Drug Meets Main Goal

MT Newswires Live

Novartis $12 Billion Bet on Avidity Is Starting to Pay Off -- Market Talk

Novartis Could Move Forward Neuromuscular Drug Approval After Early Data -- Market Talk

Europe's Big Pharma Could Win Investors' Favor With Busy End of Year -- Market Talk

Why a U.K. pharma giant is paying a 40% premium to pivot back to oncology

GSK just announced its biggest purchase in eight years to rev up cancer portfolio it had previously wound down

Argus Research Reaffirms Their Buy Rating on Novartis (NVS)

Movement Alert｜Novartis Rises 3.13% in Regular Trading, Positive Cosentyx Phase 3 Data Boosts Shares Amid Broad Pharma Rally

Novartis Says Cosentyx Shows Sustained Remission in Phase 3 Trial

MT Newswires Live

Celcuity Says Gedatolisib Outperforms Novartis' Alpelisib Plus Fulvestrant in Phase 3 Trial

MT Newswires Live

Movement Alert｜Novartis Falls 3.06% in Regular Trading, Trading at $144.97

Novartis's Next Prostate Cancer Therapy Could Raise Bar for Treatment -- Market Talk

Novartis announces results on rPFS improvements across subgroups with Pluvicto

Experimental Novartis radiopharma drug shows promise in early study

A New, Powerful Cholesterol-Lowering Drug Is on the Horizon -- WSJ

China Commerce Ministry Says Companies Include Eli Lilly, Sanofi, Novartis, Merck - Statement

THOMSON REUTERS

Big Pharma Firms Denied Certiorari by Supreme Court in Medicare Pricing Case

MT Newswires Live

Novartis Says Prostate Cancer Treatment Lowers Progression Risk By 58%

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/NVS/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"NVS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVS\",,,,,undefined,":{"symbol":"NVS","market":"US","secType":"STK","nameCN":"Novartis AG","latestPrice":158.86,"timestamp":1787342400000,"preClose":156.24,"halted":0,"volume":1183728,"hourTrading":{"tag":"盘后","latestPrice":160,"preClose":158.86,"latestTime":"19:41 EDT","volume":23557,"amount":3744520.2149,"timestamp":1787355703062,"change":1.14,"changeRate":0.007176,"amplitude":0.007176},"delay":0,"changeRate":0.016769073220686152,"floatShares":1851000000,"shares":1907999999,"eps":6.614734,"marketStatus":"Market Closed","change":2.62,"latestTime":"08-21 16:00:00 EDT","open":156.17,"high":159.715,"low":156.1,"amount":187889854.67615998,"amplitude":0.023137,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":6.614734,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":1,"adrRate":1,"exchange":"NYSE","adjPreClose":156.24,"dividendRate":0.029373,"preHourTrading":{"tag":"盘前","latestPrice":156.18,"preClose":156.24,"latestTime":"09:29 EDT","volume":12114,"amount":1892160.7668,"timestamp":1787318999428,"change":-0.06,"changeRate":-0.000384,"amplitude":0.00512},"postHourTrading":{"tag":"盘后","latestPrice":160,"preClose":158.86,"latestTime":"19:41 EDT","volume":23557,"amount":3744520.2149,"timestamp":1787355703062,"change":1.14,"changeRate":0.007176,"amplitude":0.007176},"volumeRatio":0.7274964794187035,"optionData":{"bulkOrders":[{"symbol":"NVS","call":false,"expireDate":1797570000000,"strike":"150.0","timestamp":1787321864661,"price":5.79,"volume":1100,"amount":636900,"type":"+"}]},"impliedVol":0.3301,"impliedVolPercentile":0.992},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVS\",,,,,undefined,":{"symbol":"NVS","floatShares":1851000000,"roa":"10.25%","roe":"30.35%","lyrEps":7.15,"volumeRatio":0.7274964794187035,"shares":1907999999,"dividePrice":4.66612,"high":159.715,"amplitude":0.023137,"preClose":156.24,"low":156.1,"week52Low":121.57,"pbRate":"7.30","psRate":"5.35","week52High":170.46,"institutionHeld":0.0583,"latestPrice":158.86,"eps":6.614734,"divideRate":0.029373,"volume":1183728,"delay":0,"ttmEps":6.614734,"open":156.17,"prevYearClose":137.87,"prevWeekClose":150.88,"prevMonthClose":156.15,"prevQuarterClose":156.72,"fiveDayClose":150.88,"twentyDayClose":155.01,"sixtyDayClose":151.12,"dividendPayoutRate":0.34874510374853546,"dividendFrequency":"A","dividendGrowthYears":3,"dividendGrowthRate":0.024443332061197774,"fiveYearAvgDividendRate":0.02297099205106149},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-21","symbol":"NVS","fiscalQuarterEnding":"2026/06","expectedEps":2.2,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1784606400000,"reportTimeType":"pre","actualEps":2.41},{"market":"US","date":"2026-04-28","symbol":"NVS","fiscalQuarterEnding":"2026/03","expectedEps":2.11,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777348800000,"reportTimeType":"pre","actualEps":1.99},{"date":"2026-03-11","symbol":"NVS","amount":4.77296,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-11","defaultRemindTime":1773235800000,"name":"诺华","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-16","payableDate":"2026-03-11","currency":"USD","dateTimestamp":1773201600000,"payDate":"2026-03-16"},{"market":"US","date":"2026-02-04","symbol":"NVS","fiscalQuarterEnding":"2025/12","expectedEps":1.99,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1770181200000,"reportTimeType":"pre","actualEps":1.98},{"market":"US","date":"2025-10-28","symbol":"NVS","fiscalQuarterEnding":"2025/09","expectedEps":2.26,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1761624000000,"reportTimeType":"pre","actualEps":2.25}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVS\",market:\"US\",,,undefined,":[{"executeDate":"2019-03-04","recordDate":"2019-03-05","paymentDate":"2019-03-13","value":1.861996,"currency":"USD"},{"executeDate":"2020-03-03","recordDate":"2020-03-04","paymentDate":"2020-03-12","value":1.9776197,"currency":"USD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-03-15","value":2.1959459,"currency":"USD"},{"executeDate":"2022-03-08","recordDate":"2022-03-09","paymentDate":"2022-03-17","value":3.3574492,"currency":"USD"},{"executeDate":"2023-03-09","recordDate":"2023-03-10","paymentDate":"2023-03-20","value":3.2,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1,"buy":0.2,"hold":0.4,"sell":0.3,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.4,"analysts":10,"updateTime":1767844800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NVS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NVS","date":"2026-08-21","current":24.016083,"percent":0.801123,"low":7.087581,"twenty":11.017222,"median":17.779711,"eighty":23.505678,"high":33.848621,"avg":17.547242,"sd":6.747459,"marketCap":300602507210.36},"quantilePoints":[{"date":"2021-08-27","current":22.984623,"twenty":15.530062,"median":21.84709,"eighty":27.677778,"marketCap":206493850543.31},{"date":"2021-09-03","current":22.718035,"twenty":15.538322,"median":21.869287,"eighty":27.654974,"marketCap":204098826165.09},{"date":"2021-09-10","current":21.345254,"twenty":15.550583,"median":21.869287,"eighty":27.626214,"marketCap":191765758544.03},{"date":"2021-09-17","current":20.712438,"twenty":15.559277,"median":21.84709,"eighty":27.608358,"marketCap":186080540393.19},{"date":"2021-09-24","current":20.705728,"twenty":15.579952,"median":21.783237,"eighty":27.552824,"marketCap":186020268740.41},{"date":"2021-10-01","current":20.345304,"twenty":15.600577,"median":21.698856,"eighty":27.50635,"marketCap":182782211476.64},{"date":"2021-10-08","current":20.562654,"twenty":15.609566,"median":21.649563,"eighty":27.491371,"marketCap":184734878306.34},{"date":"2021-10-15","current":20.740241,"twenty":15.618942,"median":21.463043,"eighty":27.437499,"marketCap":186330331047.78},{"date":"2021-10-22","current":21.058392,"twenty":15.627389,"median":21.428036,"eighty":27.401594,"marketCap":189188586652.7},{"date":"2021-10-29","current":18.817338,"twenty":15.635032,"median":21.347439,"eighty":27.383461,"marketCap":184541630310.6},{"date":"2021-11-05","current":19.018891,"twenty":15.647289,"median":21.317885,"eighty":27.350089,"marketCap":186518259165.92},{"date":"2021-11-12","current":18.891167,"twenty":15.654532,"median":21.179825,"eighty":27.307652,"marketCap":185265673842.84},{"date":"2021-11-19","current":18.728326,"twenty":15.663321,"median":21.048046,"eighty":27.254761,"marketCap":183668699163.22},{"date":"2021-11-26","current":18.466622,"twenty":15.669452,"median":21.012114,"eighty":27.229251,"marketCap":181102155276.87},{"date":"2021-12-03","current":18.258168,"twenty":15.672299,"median":20.862779,"eighty":27.221869,"marketCap":179057860494.36},{"date":"2021-12-10","current":18.5005,"twenty":15.679373,"median":20.754728,"eighty":27.20819,"marketCap":181434401677.24},{"date":"2021-12-17","current":19.741364,"twenty":15.68813,"median":20.712438,"eighty":27.181553,"marketCap":193603556286.26},{"date":"2021-12-23","current":19.848527,"twenty":15.692775,"median":20.705728,"eighty":27.155854,"marketCap":194654498880},{"date":"2021-12-31","current":20.088424,"twenty":15.701331,"median":20.618532,"eighty":27.138533,"marketCap":197007170988.69},{"date":"2022-01-07","current":20.258584,"twenty":15.705623,"median":20.60602,"eighty":27.121927,"marketCap":198675935418.57},{"date":"2022-01-14","current":20.570686,"twenty":15.723796,"median":20.589637,"eighty":27.105451,"marketCap":201736710825.32},{"date":"2022-01-21","current":19.970714,"twenty":15.736051,"median":20.56667,"eighty":27.061491,"marketCap":195852789238.19},{"date":"2022-01-28","current":19.465055,"twenty":15.746378,"median":20.545058,"eighty":27.059181,"marketCap":190893794335.26},{"date":"2022-02-04","current":8.029227,"twenty":15.720732,"median":20.461012,"eighty":27.056778,"marketCap":192870073011.45},{"date":"2022-02-11","current":8.018981,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":192623938080.47},{"date":"2022-02-18","current":8.065272,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":193735890248.88},{"date":"2022-02-25","current":8.114918,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":194928434328.79},{"date":"2022-03-04","current":7.836403,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":188238254501.41},{"date":"2022-03-11","current":7.721781,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":185484909723.96},{"date":"2022-03-18","current":8.057829,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":193557099512.19},{"date":"2022-03-25","current":8.071441,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":193884091322.71},{"date":"2022-04-01","current":8.094547,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":194439100004.32},{"date":"2022-04-08","current":8.638654,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":207509117437.99},{"date":"2022-04-14","current":8.640519,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":207553893767.01},{"date":"2022-04-22","current":8.353937,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":200669919872.67},{"date":"2022-04-29","current":8.131471,"twenty":15.665963,"median":20.330649,"eighty":27.053184,"marketCap":196651481774.28},{"date":"2022-05-06","current":7.881676,"twenty":15.621187,"median":20.256294,"eighty":27.03613,"marketCap":190610438695.01},{"date":"2022-05-13","current":7.895122,"twenty":15.554139,"median":20.050708,"eighty":26.799658,"marketCap":190935630327.25},{"date":"2022-05-20","current":7.981506,"twenty":15.46988,"median":19.939865,"eighty":26.712067,"marketCap":193024747095},{"date":"2022-05-27","current":8.181613,"twenty":15.438524,"median":19.636273,"eighty":26.626409,"marketCap":197864120623.02},{"date":"2022-06-03","current":8.00738,"twenty":15.393749,"median":19.478952,"eighty":26.562818,"marketCap":193650479646.81},{"date":"2022-06-10","current":7.624373,"twenty":15.34334,"median":19.163283,"eighty":26.481397,"marketCap":184387844631.82},{"date":"2022-06-17","current":7.304054,"twenty":15.298712,"median":19.077284,"eighty":26.418719,"marketCap":176641242394.35},{"date":"2022-06-24","current":7.582309,"twenty":15.27964,"median":18.986834,"eighty":26.364561,"marketCap":183370574720.06},{"date":"2022-07-01","current":7.493877,"twenty":15.250273,"median":18.900841,"eighty":26.314464,"marketCap":181231913048.72},{"date":"2022-07-08","current":7.606086,"twenty":15.23199,"median":18.869162,"eighty":26.291679,"marketCap":183945576164.31},{"date":"2022-07-15","current":7.58856,"twenty":15.202136,"median":18.806098,"eighty":26.232109,"marketCap":183521723409.93},{"date":"2022-07-22","current":8.19561,"twenty":15.18337,"median":18.71718,"eighty":26.166494,"marketCap":188351517085.2},{"date":"2022-07-29","current":8.158045,"twenty":15.157076,"median":18.647438,"eighty":26.132159,"marketCap":187488206041.27},{"date":"2022-08-05","current":8.078369,"twenty":15.110436,"median":18.578085,"eighty":26.065871,"marketCap":185657067852.22},{"date":"2022-08-12","current":8.066066,"twenty":15.073457,"median":18.515669,"eighty":25.940642,"marketCap":185374335649.61},{"date":"2022-08-19","current":8.123102,"twenty":15.02629,"median":18.4837,"eighty":25.886111,"marketCap":186685117272.05},{"date":"2022-08-26","current":7.921009,"twenty":14.971809,"median":18.427077,"eighty":25.833627,"marketCap":182040613492.93},{"date":"2022-09-02","current":7.69931,"twenty":14.889831,"median":18.390521,"eighty":25.781076,"marketCap":176945538997.44},{"date":"2022-09-09","current":7.839444,"twenty":14.847478,"median":18.352215,"eighty":25.737059,"marketCap":180166100535.63},{"date":"2022-09-16","current":7.639838,"twenty":14.800639,"median":18.279395,"eighty":25.69413,"marketCap":175578771828.6},{"date":"2022-09-23","current":7.200687,"twenty":14.715721,"median":18.250058,"eighty":25.606633,"marketCap":165486184420.18},{"date":"2022-09-30","current":7.309364,"twenty":14.666961,"median":18.233974,"eighty":25.536644,"marketCap":167983801405.08},{"date":"2022-10-07","current":7.233971,"twenty":14.612953,"median":18.210204,"eighty":25.43593,"marketCap":166251109031.05},{"date":"2022-10-14","current":7.191933,"twenty":14.497159,"median":18.168977,"eighty":25.32345,"marketCap":165284995916.46},{"date":"2022-10-21","current":7.25195,"twenty":14.457826,"median":18.113862,"eighty":25.286138,"marketCap":166664300685.15},{"date":"2022-10-28","current":7.929368,"twenty":14.315805,"median":18.077533,"eighty":25.233079,"marketCap":172836429210.02},{"date":"2022-11-04","current":8.027551,"twenty":14.283277,"median":18.007982,"eighty":25.152421,"marketCap":174976531233.09},{"date":"2022-11-11","current":8.242312,"twenty":14.244857,"median":17.98094,"eighty":25.087357,"marketCap":179657664851.58},{"date":"2022-11-18","current":8.457603,"twenty":14.191615,"median":17.955359,"eighty":24.985599,"marketCap":184350366168.97},{"date":"2022-11-25","current":8.657467,"twenty":14.143838,"median":17.845766,"eighty":24.944555,"marketCap":188706817286.19},{"date":"2022-12-02","current":8.838391,"twenty":14.078613,"median":17.783631,"eighty":24.901055,"marketCap":192650402692.03},{"date":"2022-12-09","current":9.046654,"twenty":14.034813,"median":17.713631,"eighty":24.828177,"marketCap":197189931786.84},{"date":"2022-12-16","current":8.906442,"twenty":14.013992,"median":17.636168,"eighty":24.769512,"marketCap":194133722263.41},{"date":"2022-12-23","current":8.960744,"twenty":13.971607,"median":17.554825,"eighty":24.727245,"marketCap":195317323645.23},{"date":"2022-12-30","current":8.920871,"twenty":13.914951,"median":17.505765,"eighty":24.703969,"marketCap":194448241062.22},{"date":"2023-01-06","current":9.093242,"twenty":13.856188,"median":17.48301,"eighty":24.625204,"marketCap":198205406557.8},{"date":"2023-01-13","current":9.002411,"twenty":13.821776,"median":17.460761,"eighty":24.583673,"marketCap":196225557627.91},{"date":"2023-01-20","current":9.051584,"twenty":13.776842,"median":17.424808,"eighty":24.543498,"marketCap":197297374275.26},{"date":"2023-01-27","current":8.847624,"twenty":13.673815,"median":17.405208,"eighty":24.464769,"marketCap":192851676130.76},{"date":"2023-02-03","current":26.243556,"twenty":13.627087,"median":17.400788,"eighty":24.459661,"marketCap":182523930790.97},{"date":"2023-02-10","current":26.294961,"twenty":13.627087,"median":17.400788,"eighty":24.459661,"marketCap":182881448586.32},{"date":"2023-02-17","current":26.374513,"twenty":13.627087,"median":17.400788,"eighty":24.459661,"marketCap":183434736554.71},{"date":"2023-02-24","current":26.177477,"twenty":13.627087,"median":17.400788,"eighty":24.459661,"marketCap":182064354704.07},{"date":"2023-03-03","current":25.765519,"twenty":13.627087,"median":17.400788,"eighty":24.459661,"marketCap":179199184580.8},{"date":"2023-03-10","current":24.700467,"twenty":13.627087,"median":17.400788,"eighty":24.459661,"marketCap":171791749395.01},{"date":"2023-03-17","current":26.915798,"twenty":13.627087,"median":17.400788,"eighty":24.459661,"marketCap":187199370174.87},{"date":"2023-03-24","current":27.246033,"twenty":13.627087,"median":17.400788,"eighty":24.543498,"marketCap":189496154839.06},{"date":"2023-03-31","current":30.054098,"twenty":13.630004,"median":17.402998,"eighty":24.587255,"marketCap":209026250254.21},{"date":"2023-04-06","current":31.533443,"twenty":13.630004,"median":17.402998,"eighty":24.625118,"marketCap":219315097125.45},{"date":"2023-04-14","current":32.274976,"twenty":13.627087,"median":17.400788,"eighty":24.706379,"marketCap":224472453860.2},{"date":"2023-04-21","current":32.553317,"twenty":13.627087,"median":17.400788,"eighty":24.770643,"marketCap":226408322073.89},{"date":"2023-04-28","current":30.395591,"twenty":13.627087,"median":17.400788,"eighty":24.870311,"marketCap":213559421622.35},{"date":"2023-05-05","current":31.378954,"twenty":13.624171,"median":17.400508,"eighty":24.92381,"marketCap":220468531572.95},{"date":"2023-05-12","current":30.870482,"twenty":13.624171,"median":17.400508,"eighty":24.976352,"marketCap":216896002905.77},{"date":"2023-05-19","current":29.854888,"twenty":13.624171,"median":17.400508,"eighty":25.035144,"marketCap":209760441249.27},{"date":"2023-05-26","current":29.284412,"twenty":13.624171,"median":17.400508,"eighty":25.151225,"marketCap":205752279633.25},{"date":"2023-06-02","current":29.357697,"twenty":13.624171,"median":17.400508,"eighty":25.224214,"marketCap":206267176913.22},{"date":"2023-06-09","current":29.886389,"twenty":13.624171,"median":17.400508,"eighty":25.298929,"marketCap":209981771535.32},{"date":"2023-06-16","current":30.321305,"twenty":13.624171,"median":17.400508,"eighty":25.414052,"marketCap":213037486310.78},{"date":"2023-06-23","current":30.190139,"twenty":13.621254,"median":17.400228,"eighty":25.482171,"marketCap":212115917863.59},{"date":"2023-06-30","current":29.926736,"twenty":13.621254,"median":17.400228,"eighty":25.530882,"marketCap":210265246516.29},{"date":"2023-07-07","current":28.234527,"twenty":13.621254,"median":17.400228,"eighty":25.631737,"marketCap":198375788384.16},{"date":"2023-07-14","current":29.505671,"twenty":13.621254,"median":17.400228,"eighty":25.721137,"marketCap":207306851165.12},{"date":"2023-07-21","current":28.497251,"twenty":13.702614,"median":17.40584,"eighty":25.765158,"marketCap":217946975867.36},{"date":"2023-07-28","current":28.10544,"twenty":13.702614,"median":17.431322,"eighty":25.810163,"marketCap":214950408672.37},{"date":"2023-08-04","current":27.560871,"twenty":13.702614,"median":17.466898,"eighty":25.855767,"marketCap":210785535427.99},{"date":"2023-08-11","current":28.108004,"twenty":13.702614,"median":17.491087,"eighty":25.920889,"marketCap":214970019886.42},{"date":"2023-08-18","current":27.500668,"twenty":13.716822,"median":17.543114,"eighty":25.999939,"marketCap":210325106917.85},{"date":"2023-08-25","current":27.490856,"twenty":13.716822,"median":17.630823,"eighty":26.112124,"marketCap":210250065949.08},{"date":"2023-09-01","current":27.33691,"twenty":13.716822,"median":17.676024,"eighty":26.137251,"marketCap":209072687172.76},{"date":"2023-09-08","current":26.684355,"twenty":13.831992,"median":17.775785,"eighty":26.164037,"marketCap":204081948408.26},{"date":"2023-09-15","current":27.8918,"twenty":13.863753,"median":17.829937,"eighty":26.195299,"marketCap":213316484771.89},{"date":"2023-09-22","current":27.529162,"twenty":13.863753,"median":17.948734,"eighty":26.256036,"marketCap":210543032637.27},{"date":"2023-09-29","current":27.704599,"twenty":13.863753,"median":17.977965,"eighty":26.294822,"marketCap":211884773857.62},{"date":"2023-10-06","current":26.136777,"twenty":13.863753,"median":17.998187,"eighty":26.307358,"marketCap":199894070259.72},{"date":"2023-10-13","current":26.099935,"twenty":13.931808,"median":18.076116,"eighty":26.318536,"marketCap":199612304286.36},{"date":"2023-10-20","current":25.606741,"twenty":13.931808,"median":18.102011,"eighty":26.318536,"marketCap":195840357582.32},{"date":"2023-10-27","current":24.415836,"twenty":13.914417,"median":18.144394,"eighty":26.326723,"marketCap":191322491088.71},{"date":"2023-11-03","current":24.121849,"twenty":13.914417,"median":18.186711,"eighty":26.326723,"marketCap":189018809684.75},{"date":"2023-11-10","current":24.455041,"twenty":13.914417,"median":18.226261,"eighty":26.326723,"marketCap":191629701060.59},{"date":"2023-11-17","current":24.852995,"twenty":13.914417,"median":18.240532,"eighty":26.326723,"marketCap":194748066897.24},{"date":"2023-11-24","current":25.763747,"twenty":13.914417,"median":18.264257,"eighty":26.326723,"marketCap":201884721514.42},{"date":"2023-12-01","current":25.681448,"twenty":13.914417,"median":18.308684,"eighty":26.326723,"marketCap":201239827121.68},{"date":"2023-12-08","current":25.351528,"twenty":13.918256,"median":18.360699,"eighty":26.322856,"marketCap":198654572969.12},{"date":"2023-12-15","current":25.72582,"twenty":13.918256,"median":18.394754,"eighty":26.322856,"marketCap":201587524553.81},{"date":"2023-12-22","current":25.978676,"twenty":13.918256,"median":18.447118,"eighty":26.322856,"marketCap":203568905697.84},{"date":"2023-12-29","current":26.529514,"twenty":13.914417,"median":18.483927,"eighty":26.348002,"marketCap":207885278188.64},{"date":"2024-01-05","current":27.901829,"twenty":13.910577,"median":18.51381,"eighty":26.370883,"marketCap":218638738608.88},{"date":"2024-01-12","current":28.036514,"twenty":13.910577,"median":18.571472,"eighty":26.422243,"marketCap":219694129152.93},{"date":"2024-01-19","current":28.352927,"twenty":13.906738,"median":18.628586,"eighty":26.470944,"marketCap":222173534575.94},{"date":"2024-01-26","current":27.949174,"twenty":13.910577,"median":18.684776,"eighty":26.521392,"marketCap":219009721879.32},{"date":"2024-02-02","current":14.397684,"twenty":13.910577,"median":18.71718,"eighty":26.537684,"marketCap":213805607321.99},{"date":"2024-02-09","current":13.900537,"twenty":13.868427,"median":18.71718,"eighty":26.537684,"marketCap":206422982529.79},{"date":"2024-02-16","current":13.813113,"twenty":13.687988,"median":18.71718,"eighty":26.537684,"marketCap":205124721398.18},{"date":"2024-02-23","current":14.305017,"twenty":13.687988,"median":18.71718,"eighty":26.537684,"marketCap":212429491580.85},{"date":"2024-03-01","current":14.052638,"twenty":13.704706,"median":18.708576,"eighty":26.536229,"marketCap":208681673875.32},{"date":"2024-03-08","current":13.812509,"twenty":13.704706,"median":18.708576,"eighty":26.536229,"marketCap":205115751567.13},{"date":"2024-03-15","current":13.350493,"twenty":13.599085,"median":18.708576,"eighty":26.536229,"marketCap":198254813990.44},{"date":"2024-03-22","current":14.193287,"twenty":13.599085,"median":18.708576,"eighty":26.536229,"marketCap":210770303493.35},{"date":"2024-03-28","current":14.305417,"twenty":13.599085,"median":18.708576,"eighty":26.536229,"marketCap":212435439752.63},{"date":"2024-04-05","current":14.023817,"twenty":13.576499,"median":18.71718,"eighty":26.537684,"marketCap":208253683585.27},{"date":"2024-04-12","current":13.933033,"twenty":13.576499,"median":18.71718,"eighty":26.537684,"marketCap":206905536915.4},{"date":"2024-04-19","current":13.841097,"twenty":13.576499,"median":18.71718,"eighty":26.537684,"marketCap":205540289930.65},{"date":"2024-04-26","current":13.116641,"twenty":13.098986,"median":18.708576,"eighty":26.536229,"marketCap":199963177263.62},{"date":"2024-05-03","current":12.901312,"twenty":12.986611,"median":18.708576,"eighty":26.536229,"marketCap":196680491183.63},{"date":"2024-05-10","current":13.62556,"twenty":12.986611,"median":18.708576,"eighty":26.536229,"marketCap":207721668262.32},{"date":"2024-05-17","current":13.811142,"twenty":12.986611,"median":18.708576,"eighty":26.536229,"marketCap":210550870720.47},{"date":"2024-05-24","current":13.427426,"twenty":12.986611,"median":18.708576,"eighty":26.536229,"marketCap":204701108813.04},{"date":"2024-05-31","current":13.801388,"twenty":12.986611,"median":18.708576,"eighty":26.536229,"marketCap":210402159392.6},{"date":"2024-06-07","current":14.179941,"twenty":12.986611,"median":18.708576,"eighty":26.536229,"marketCap":216173203205.72},{"date":"2024-06-14","current":14.268027,"twenty":12.986611,"median":18.708576,"eighty":26.536229,"marketCap":217516057210.18},{"date":"2024-06-21","current":14.065609,"twenty":12.9792,"median":18.71718,"eighty":26.537684,"marketCap":214430202954.07},{"date":"2024-06-28","current":14.323938,"twenty":12.9792,"median":18.71718,"eighty":26.537684,"marketCap":218368442284.67},{"date":"2024-07-05","current":14.408073,"twenty":12.9792,"median":18.71718,"eighty":26.537684,"marketCap":219651075334.28},{"date":"2024-07-12","current":14.975492,"twenty":12.9792,"median":18.71718,"eighty":26.537684,"marketCap":228301366570.5},{"date":"2024-07-19","current":13.268905,"twenty":12.9792,"median":18.699973,"eighty":26.537684,"marketCap":214624531043.21},{"date":"2024-07-26","current":13.816724,"twenty":12.9792,"median":18.647438,"eighty":26.537684,"marketCap":223485507190.68},{"date":"2024-08-02","current":14.090751,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":227917912437.95},{"date":"2024-08-09","current":13.993585,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":226346245790.31},{"date":"2024-08-16","current":14.328569,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":231764593445.89},{"date":"2024-08-23","current":14.823692,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":239773222258.92},{"date":"2024-08-30","current":15.052963,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":243481670102.69},{"date":"2024-09-06","current":14.666925,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":237237514593.86},{"date":"2024-09-13","current":14.492452,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":234415404725.28},{"date":"2024-09-20","current":14.554631,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":235421158822.98},{"date":"2024-09-27","current":14.550661,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":235356938553.67},{"date":"2024-10-04","current":14.222187,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":230043877046.97},{"date":"2024-10-11","current":14.520941,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":234876221387.16},{"date":"2024-10-18","current":14.601536,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":236179853851.57},{"date":"2024-10-25","current":14.25487,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":230572528460.12},{"date":"2024-11-01","current":12.467183,"twenty":12.48247,"median":18.630113,"eighty":26.537684,"marketCap":219459823948.45},{"date":"2024-11-08","current":12.062797,"twenty":12.124753,"median":18.630113,"eighty":26.537684,"marketCap":212341406668.12},{"date":"2024-11-15","current":11.7308,"twenty":11.840322,"median":18.630113,"eighty":26.537684,"marketCap":206497268589.51},{"date":"2024-11-22","current":11.890254,"twenty":11.704725,"median":18.630113,"eighty":26.537684,"marketCap":209304132283.23},{"date":"2024-11-29","current":12.013144,"twenty":11.704725,"median":18.630113,"eighty":26.537684,"marketCap":211467357651.39},{"date":"2024-12-06","current":11.627758,"twenty":11.645281,"median":18.630113,"eighty":26.537684,"marketCap":204683425855.25},{"date":"2024-12-13","current":11.155398,"twenty":11.272574,"median":18.630113,"eighty":26.537684,"marketCap":196368468258.14},{"date":"2024-12-20","current":11.016834,"twenty":11.072841,"median":18.630113,"eighty":26.537684,"marketCap":193929327376.35},{"date":"2024-12-27","current":11.195581,"twenty":11.031387,"median":18.630113,"eighty":26.537684,"marketCap":197075816359.8},{"date":"2025-01-03","current":11.113975,"twenty":11.029071,"median":18.630113,"eighty":26.537684,"marketCap":195639289814.34},{"date":"2025-01-10","current":11.275607,"twenty":11.023437,"median":18.638776,"eighty":26.539138,"marketCap":198484509661.91},{"date":"2025-01-17","current":11.097752,"twenty":11.023437,"median":18.638776,"eighty":26.539138,"marketCap":195353731331.02},{"date":"2025-01-24","current":11.330187,"twenty":11.023437,"median":18.638776,"eighty":26.539138,"marketCap":199445294080.33},{"date":"2025-01-31","current":17.385101,"twenty":11.023437,"median":18.638776,"eighty":26.539138,"marketCap":207595485091.71},{"date":"2025-02-07","current":17.614207,"twenty":11.023437,"median":18.638776,"eighty":26.539138,"marketCap":210331245815.87},{"date":"2025-02-14","current":17.568499,"twenty":11.023437,"median":18.492327,"eighty":26.539138,"marketCap":209785454321.8},{"date":"2025-02-21","current":18.05046,"twenty":11.023437,"median":18.437098,"eighty":26.539138,"marketCap":215540543803.02},{"date":"2025-02-28","current":17.913341,"twenty":11.023437,"median":18.437098,"eighty":26.539138,"marketCap":213903205942.89},{"date":"2025-03-07","current":19.003167,"twenty":11.017803,"median":18.484154,"eighty":26.540593,"marketCap":226916823474.23},{"date":"2025-03-14","current":18.012835,"twenty":11.017803,"median":18.5005,"eighty":26.540593,"marketCap":215091268671.02},{"date":"2025-03-21","current":17.849274,"twenty":11.017803,"median":18.560503,"eighty":26.540593,"marketCap":213138179550.63},{"date":"2025-03-28","current":17.788275,"twenty":11.017803,"median":18.560503,"eighty":26.540593,"marketCap":212409793703.96},{"date":"2025-04-04","current":17.082813,"twenty":11.017803,"median":18.560503,"eighty":26.540593,"marketCap":203985871294.58},{"date":"2025-04-11","current":16.768387,"twenty":11.023437,"median":18.538324,"eighty":26.539138,"marketCap":200231305726.4},{"date":"2025-04-17","current":17.580919,"twenty":11.023437,"median":18.538324,"eighty":26.539138,"marketCap":209933754161.38},{"date":"2025-04-25","current":17.730023,"twenty":11.017803,"median":18.560503,"eighty":26.540593,"marketCap":211714201787.97},{"date":"2025-05-02","current":17.380553,"twenty":11.017803,"median":18.560503,"eighty":26.540593,"marketCap":223496525732.55},{"date":"2025-05-09","current":16.696941,"twenty":11.017803,"median":18.560503,"eighty":26.540593,"marketCap":214705962988.5},{"date":"2025-05-16","current":16.597916,"twenty":11.017803,"median":18.560503,"eighty":26.540593,"marketCap":213432604432.69},{"date":"2025-05-23","current":17.060987,"twenty":11.017803,"median":18.560503,"eighty":26.540593,"marketCap":219387243488.65},{"date":"2025-05-30","current":17.399171,"twenty":11.017803,"median":18.560503,"eighty":26.540593,"marketCap":223735936665.37},{"date":"2025-06-06","current":18.03736,"twenty":11.017803,"median":18.560503,"eighty":26.540593,"marketCap":231942405204.56},{"date":"2025-06-13","current":18.199363,"twenty":11.017803,"median":18.560503,"eighty":26.540593,"marketCap":234025607559.44},{"date":"2025-06-20","current":17.650046,"twenty":11.017609,"median":18.580101,"eighty":26.542981,"marketCap":226961939753.89},{"date":"2025-06-27","current":18.306798,"twenty":11.017609,"median":18.580101,"eighty":26.542981,"marketCap":235407114231.28},{"date":"2025-07-03","current":18.551811,"twenty":11.017609,"median":18.637113,"eighty":26.542981,"marketCap":238557726687.71},{"date":"2025-07-11","current":18.390521,"twenty":11.017609,"median":18.669713,"eighty":26.542981,"marketCap":236483711168.25},{"date":"2025-07-18","current":16.259664,"twenty":11.017609,"median":18.669713,"eighty":26.542981,"marketCap":222009457365.11},{"date":"2025-07-25","current":16.563324,"twenty":11.017609,"median":18.637113,"eighty":26.542981,"marketCap":226155626091.5},{"date":"2025-08-01","current":16.440167,"twenty":11.017609,"median":18.51407,"eighty":26.542981,"marketCap":224474032398.53},{"date":"2025-08-08","current":16.510159,"twenty":11.017609,"median":18.467955,"eighty":26.542981,"marketCap":225429723871.84},{"date":"2025-08-15","current":17.461548,"twenty":11.017609,"median":18.425945,"eighty":26.542981,"marketCap":238419967163.07},{"date":"2025-08-22","current":17.895944,"twenty":11.017609,"median":18.375177,"eighty":26.542981,"marketCap":244351227512.78},{"date":"2025-08-29","current":17.881488,"twenty":11.017609,"median":18.270567,"eighty":26.537163,"marketCap":244153835649.81},{"date":"2025-09-05","current":18.285354,"twenty":11.017415,"median":18.229362,"eighty":26.479478,"marketCap":249668226793.84},{"date":"2025-09-12","current":17.610165,"twenty":11.017609,"median":18.178951,"eighty":26.409491,"marketCap":240449195357.11},{"date":"2025-09-19","current":17.504643,"twenty":11.017609,"median":18.112179,"eighty":26.343162,"marketCap":239008405447.73},{"date":"2025-09-26","current":17.430562,"twenty":11.017609,"median":18.052715,"eighty":26.273346,"marketCap":237996893599.29},{"date":"2025-10-03","current":18.668277,"twenty":11.017609,"median":18.04524,"eighty":26.231511,"marketCap":254896663088.94},{"date":"2025-10-10","current":18.461585,"twenty":11.017609,"median":18.04524,"eighty":26.194217,"marketCap":252074474123.51},{"date":"2025-10-17","current":18.576403,"twenty":11.017609,"median":18.04524,"eighty":26.169297,"marketCap":253642205163.25},{"date":"2025-10-24","current":18.54096,"twenty":11.017609,"median":18.04524,"eighty":26.158789,"marketCap":253158264822.59},{"date":"2025-10-31","current":16.507966,"twenty":11.017609,"median":18.019571,"eighty":26.155409,"marketCap":237599158832.7},{"date":"2025-11-07","current":16.845954,"twenty":11.017609,"median":17.969199,"eighty":26.136981,"marketCap":242463820785.43},{"date":"2025-11-14","current":17.5755,"twenty":11.017609,"median":17.930999,"eighty":26.069026,"marketCap":252964172798.43},{"date":"2025-11-21","current":17.029478,"twenty":11.017609,"median":17.880595,"eighty":25.968143,"marketCap":245105269747.58},{"date":"2025-11-28","current":17.307861,"twenty":11.017609,"median":17.870342,"eighty":25.925514,"marketCap":249112034138.13},{"date":"2025-12-05","current":17.800946,"twenty":11.017609,"median":17.835775,"eighty":25.855966,"marketCap":256209018258.22},{"date":"2025-12-12","current":17.706311,"twenty":11.017609,"median":17.787573,"eighty":25.797727,"marketCap":254846938368.18},{"date":"2025-12-19","current":18.232445,"twenty":11.017609,"median":17.787573,"eighty":25.764101,"marketCap":262419590357.79},{"date":"2025-12-26","current":18.662776,"twenty":11.017609,"median":17.787573,"eighty":25.734368,"marketCap":268613330664.48},{"date":"2026-01-02","current":18.434108,"twenty":11.017609,"median":17.787573,"eighty":25.682801,"marketCap":265322116830.26},{"date":"2026-01-09","current":19.02178,"twenty":11.017609,"median":17.787573,"eighty":25.605403,"marketCap":273780485767.91},{"date":"2026-01-16","current":19.197678,"twenty":11.017609,"median":17.787573,"eighty":25.542524,"marketCap":276312184159.65},{"date":"2026-01-23","current":19.503645,"twenty":11.017609,"median":17.787573,"eighty":25.495799,"marketCap":280715956481.2},{"date":"2026-01-30","current":19.905011,"twenty":11.017609,"median":17.787573,"eighty":25.479385,"marketCap":286492832439.72},{"date":"2026-02-06","current":21.043428,"twenty":11.017609,"median":17.787573,"eighty":25.479385,"marketCap":294271302563.44},{"date":"2026-02-13","current":22.203005,"twenty":11.017609,"median":17.787573,"eighty":25.416738,"marketCap":310486823189.05},{"date":"2026-02-20","current":22.25691,"twenty":11.017609,"median":17.787573,"eighty":25.364513,"marketCap":311240631144.07},{"date":"2026-02-27","current":23.006227,"twenty":11.017609,"median":17.787573,"eighty":25.364513,"marketCap":321719091625.43},{"date":"2026-03-06","current":21.477358,"twenty":11.017609,"median":17.787573,"eighty":25.364513,"marketCap":300339385211.53},{"date":"2026-03-13","current":21.112595,"twenty":11.017609,"median":17.787573,"eighty":25.364513,"marketCap":295238522824.98},{"date":"2026-03-20","current":19.934673,"twenty":11.017609,"median":17.787573,"eighty":25.364513,"marketCap":278766472161.56},{"date":"2026-03-27","current":20.470623,"twenty":11.017609,"median":17.787573,"eighty":25.364513,"marketCap":286261195522.31},{"date":"2026-04-02","current":21.063446,"twenty":11.017609,"median":17.787573,"eighty":25.364513,"marketCap":294551235859.72},{"date":"2026-04-10","current":21.026965,"twenty":11.017609,"median":17.787573,"eighty":25.364513,"marketCap":294041066170.98},{"date":"2026-04-17","current":20.678364,"twenty":11.017609,"median":17.787573,"eighty":25.364513,"marketCap":289166251097.48},{"date":"2026-04-24","current":19.798184,"twenty":11.017609,"median":17.787573,"eighty":25.364513,"marketCap":276857799374.71},{"date":"2026-05-01","current":20.896694,"twenty":11.017609,"median":17.787573,"eighty":25.364513,"marketCap":282815856183.9},{"date":"2026-05-08","current":20.544352,"twenty":11.017609,"median":17.787573,"eighty":25.364513,"marketCap":278047260231.64},{"date":"2026-05-15","current":21.000534,"twenty":11.017609,"median":17.787573,"eighty":25.364513,"marketCap":284221225649.8},{"date":"2026-05-22","current":21.340155,"twenty":11.017609,"median":17.787573,"eighty":25.364513,"marketCap":288817650513.16},{"date":"2026-05-29","current":21.180839,"twenty":11.017415,"median":17.786871,"eighty":25.377498,"marketCap":286661475206.57},{"date":"2026-06-05","current":20.232349,"twenty":11.017609,"median":17.787573,"eighty":25.316529,"marketCap":273824610935.58},{"date":"2026-06-12","current":20.642069,"twenty":11.017609,"median":17.787573,"eighty":25.004504,"marketCap":279369763360.09},{"date":"2026-06-18","current":19.877701,"twenty":11.017609,"median":17.787573,"eighty":24.858656,"marketCap":269024815859.26},{"date":"2026-06-26","current":21.104493,"twenty":11.017415,"median":17.786871,"eighty":24.612204,"marketCap":285628212001.58},{"date":"2026-07-02","current":21.579808,"twenty":11.017415,"median":17.786871,"eighty":24.540686,"marketCap":292061122489.06},{"date":"2026-07-10","current":20.837186,"twenty":11.017415,"median":17.786871,"eighty":24.369202,"marketCap":282010474164.2},{"date":"2026-07-17","current":20.914866,"twenty":11.017415,"median":17.786871,"eighty":23.429796,"marketCap":283061797351.46},{"date":"2026-07-24","current":23.140962,"twenty":11.017415,"median":17.786871,"eighty":23.311582,"marketCap":295209244472.19},{"date":"2026-07-31","current":23.385351,"twenty":11.017222,"median":17.779711,"eighty":23.435873,"marketCap":298326926288.12},{"date":"2026-08-07","current":23.099285,"twenty":11.017222,"median":17.779711,"eighty":23.435873,"marketCap":294677580997.8},{"date":"2026-08-14","current":22.451031,"twenty":11.017222,"median":17.779711,"eighty":23.435873,"marketCap":286407803742.49},{"date":"2026-08-21","current":23.56373,"twenty":11.017222,"median":17.779711,"eighty":23.505678,"marketCap":300602507210.36}],"updateTime":1787507495471},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVS\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2642864832","title":"Bank of America Securities Remains a Buy on Novartis (NVS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642864832","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642864832?lang=en_us&edition=fundamental","pubTime":"2026-06-11 18:57","pubTimestamp":1781175440,"startTime":"0","endTime":"0","summary":"In a report released today, Sachin Jain from Bank of America Securities maintained a Buy rating on Novartis, with a price target of CHF140.00. Jain...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-buy-on-novartis-nvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bank-of-america-securities-remains-a-buy-on-novartis-nvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0149725797.USD","LU1804176565.USD","LU0130517989.USD","IE00BFXG1179.USD","LU2129689605.HKD","IE00BJT1NW94.SGD","LU0310800965.SGD","LU1201861165.SGD","IE0001KFT4U8.USD","LU1718418525.SGD","LU0234570918.USD","BK4007","BK4534","IE00B1BXHZ80.USD","IE00B7SZLL34.SGD","LU0321505868.SGD","LU1506573853.SGD","NVS","LU0052756011.USD","IE00B19Z3581.USD","BAC","IE00BFTCPJ56.SGD","LU0868494617.USD","BK4207","IE00B2B36J28.USD","LU0640476718.USD","LU1201861249.SGD","LU1668664300.SGD","LU2596442595.SGD","IE0009355771.USD","LU0648000940.SGD","BK4582","LU0211331839.USD","IE00B4R5TH58.HKD","LU0320765489.SGD","LU0477156953.USD","LU2129689431.USD","LU0130103400.USD","PGF","IE0034235188.USD","LU0314106906.USD","LU1035773651.USD","LU1162221912.USD","LU1880398554.USD","LU0320765646.SGD","IE00BBT3K403.USD","IE00BKVL7J92.USD","LU1267930227.SGD","LU0203347892.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642428611","title":"Novartis announces biomarker cohort in study of del-brax met primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2642428611","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642428611?lang=en_us&edition=fundamental","pubTime":"2026-06-11 18:47","pubTimestamp":1781174852,"startTime":"0","endTime":"0","summary":"Novartis (NVS) announced that the biomarker cohort of the Fortitude Phase I/II study of del-brax met its primary and key secondary endpoints, with ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-announces-biomarker-cohort-in-study-of-del-brax-met-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-announces-biomarker-cohort-in-study-of-del-brax-met-primary-endpoint-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0002141913.USD","IE00BJJMRZ35.SGD","LU0320765489.SGD","NVS","BK4588","IE00BJT1NW94.SGD","BK4585","LU0070302665.USD","BK4007","IE00B2B36J28.USD","BK4578","IE0009355771.USD","BK4532","LU0211331839.USD","LU0208291251.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642283902","title":"Novartis Says Early-to-Mid Stage Study for Muscular Dystrophy Drug Meets Main Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2642283902","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642283902?lang=en_us&edition=fundamental","pubTime":"2026-06-11 18:00","pubTimestamp":1781172020,"startTime":"0","endTime":"0","summary":"Novartis (NVS) said Thursday a phase I/II study of its experimental therapy, del-brax, met both primary and key secondary endpoints in patients with facioscapulohumeral muscular dystrophy.The drugmake","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU0070302665.USD","IE00BJT1NW94.SGD","BK4578","LU0211331839.USD","IE0009355771.USD","LU0208291251.USD","BK4588","NVS","BK4007","IE00B4R5TH58.HKD","LU0320765489.SGD","BK4532","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642407212","title":"Novartis $12 Billion Bet on Avidity Is Starting to Pay Off -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2642407212","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642407212?lang=en_us&edition=fundamental","pubTime":"2026-06-11 16:34","pubTimestamp":1781166840,"startTime":"0","endTime":"0","summary":"Copyright (c) 2026 Dow Jones & Company, Inc.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BJT1NW94.SGD","BK4588","BK4007","BK4532","LU0070302665.USD","LU0320765489.SGD","IE00B4R5TH58.HKD","BK4578","IE0009355771.USD","LU0208291251.USD","LU0211331839.USD","NVS","IE0002141913.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642401338","title":"Novartis Could Move Forward Neuromuscular Drug Approval After Early Data -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2642401338","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642401338?lang=en_us&edition=fundamental","pubTime":"2026-06-11 14:41","pubTimestamp":1781160060,"startTime":"0","endTime":"0","summary":"Copyright (c) 2026 Dow Jones & Company, Inc.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Novartis Could Move Forward Neuromuscular Drug Approval After Early Data -- Market Talk","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVS","IE00BJJMRZ35.SGD","BK4007","IE00BJT1NW94.SGD","LU0070302665.USD","LU0208291251.USD","LU0320765489.SGD","BK4585","BK4588","BK4532","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU0211331839.USD","BK4578","IE0009355771.USD","IE00BFTCPJ56.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642424085","title":"Europe's Big Pharma Could Win Investors' Favor With Busy End of Year -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2642424085","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642424085?lang=en_us&edition=fundamental","pubTime":"2026-06-10 22:34","pubTimestamp":1781102040,"startTime":"0","endTime":"0","summary":"1434 GMT - Big European pharmaceutical companies have a busy second half of the year, with several key events that could help them build positive outlooks and win investors' favor, Bank of America analysts say in a note. Novartis and AstraZeneca have the busiest schedules in terms of results of clinical studies, the analysts say. At GSK and Sanofi, recently appointed CEOs are expected to provide updates on their plans alongside second-quarter earnings, they add. For Novo Nordisk, the main focus remains on prescription trends for its obesity and diabetes products, BofA says. Roche faces a quieter second half, but the launch of its new breast-cancer drug giredestrant will be key, the analysts write. The Stoxx Europe 600 Health Care index is up 0.5%. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","GSK.UK","LU2417539215.USD","LU0889565916.HKD","LU1093756325.SGD","LU2237443978.SGD","NVOX","LU0211331839.USD","LU2456880835.USD","LU0154236417.USD","IE00BKVL7J92.USD","IE00B4R5TH58.HKD","BK4007","IE0002141913.USD","LU2236285917.USD","GSK","IE0009355771.USD","BK4588","IE00BJJMRZ35.SGD","LU1093756168.USD","LU2237443622.USD","LU0289739699.SGD","IE00B3T34201.USD","LU0109394709.USD","LU2237443549.SGD","BK4578","BK4585","NVOH","NVS","BK4568","IE00BZ1G4Q59.USD","LU0208291251.USD","LU0058720904.USD","LU2237443382.USD","LU0320765489.SGD","AZNH","LU1829250122.USD","IE00BFTCPJ56.SGD","RHHBY","IE00B2B36J28.USD","LU2237443895.HKD","GSKH","BK4599","IE00BJT1NW94.SGD","LU2237443465.HKD","LU0320765992.SGD","BK4532","LU0070302665.USD","NVO","03165","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642463396","title":"Why a U.K. pharma giant is paying a 40% premium to pivot back to oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2642463396","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642463396?lang=en_us&edition=fundamental","pubTime":"2026-06-09 16:39","pubTimestamp":1780994340,"startTime":"0","endTime":"0","summary":"Under a new CEO, GSK makes a big bet on cancer drugs. GSK on Tuesday struck a deal to buy Nuvalent for $10.6 billion.U.K. pharmaceutical giant GSK on Tuesday struck a $10.6 billion deal to buy U.S.-listed biotech company Nuvalent, its biggest acquisition in eight years as it seeks to bolster the cancer portfolio it had previously trimmed.GSK last struck a deal of that size in the 2018 deal to buy Novartis out of its consumer healthcare joint venture that later would become Haleon. Novartis also was the counterparty in the complicated 2014 deal in which GSK swapped its oncology portfolio for the Swiss firm's vaccines business.Though it grew by 43% last year, oncology revenue only accounted for GBP2 billion  of GSK's GBP32.67 billion in revenue.Now, GSK is revving up its oncology business once again in buying the Boston company  for $124 per share in cash, a 40% premium to Monday's close in the first major move since new CEO Luke Miels took over the company.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","BK4585","IE00BFTCPJ56.SGD","LU0208291251.USD","NUVL","BK4578","IE0002141913.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","GSKH","IE00B4R5TH58.HKD","BK4007","BK4588","GSK","BK4139","NVS","BK4532","BK4539","LU0070302665.USD","IE00BJT1NW94.SGD","LU0211331839.USD","GSK.UK","LU0320765489.SGD","LU1829250122.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642450699","title":"GSK just announced its biggest purchase in eight years to rev up cancer portfolio it had previously wound down","url":"https://stock-news.laohu8.com/highlight/detail?id=2642450699","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642450699?lang=en_us&edition=fundamental","pubTime":"2026-06-09 15:37","pubTimestamp":1780990620,"startTime":"0","endTime":"0","summary":"GSK on Tuesday struck a deal to buy Nuvalent for $10.6 billion.U.K. pharmaceutical giant GSK on Tuesday struck a $10.6 billion deal to buy U.S.-listed biotech company Nuvalent, its biggest acquisition in eight years as it seeks to bolster the cancer portfolio it had previously trimmed.GSK last struck a deal of that size in the 2018 deal to buy Novartis out of its consumer healthcare joint venture that later would become Haleon. Novartis also was the counterparty in the complicated 2014 deal in which GSK swapped its oncology portfolio for the Swiss firm's vaccines business.Though it grew by 43% last year, oncology revenue only accounted for GBP2 billion  of GSK's GBP32.67 billion in revenue.Now, GSK is revving up its oncology business once again in buying the Boston company  for $124 per share in cash, a 40% premium to Monday's close in the first major move since new CEO Luke Miels took over the company.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSK","IE0009355771.USD","IE00BJT1NW94.SGD","LU0208291251.USD","BK4532","GSK.UK","GSKH","BK4007","LU0320765489.SGD","LU1829250122.USD","NUVL","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4578","BK4585","BK4139","BK4539","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0070302665.USD","BK4588","NVS","LU0211331839.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641414425","title":"Argus Research Reaffirms Their Buy Rating on Novartis (NVS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2641414425","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641414425?lang=en_us&edition=fundamental","pubTime":"2026-06-06 01:57","pubTimestamp":1780682278,"startTime":"0","endTime":"0","summary":"Argus Research analyst Jasper Hellweg maintained a Buy rating on Novartis yesterday and set a price target of $160.00. Hellweg covers the Healthcar...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/argus-research-reaffirms-their-buy-rating-on-novartis-nvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/argus-research-reaffirms-their-buy-rating-on-novartis-nvs-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111582137","title":"Movement Alert｜Novartis Rises 3.13% in Regular Trading, Positive Cosentyx Phase 3 Data Boosts Shares Amid Broad Pharma Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1111582137","media":"Market Focus","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111582137?lang=en_us&edition=fundamental","pubTime":"2026-06-05 03:22","pubTimestamp":1780600945,"startTime":"0","endTime":"0","summary":"On June 5, Novartis rose 3.13% in regular trading, trading at $148.185/share, with trading volume of $275 million. The move was driven by positive late-stage clinical trial results for its core...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640186758","title":"Novartis Says Cosentyx Shows Sustained Remission in Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2640186758","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640186758?lang=en_us&edition=fundamental","pubTime":"2026-06-04 02:32","pubTimestamp":1780511578,"startTime":"0","endTime":"0","summary":"Novartis (NVS) said Wednesday new Cosentyx data from a late-stage trial in polymyalgia rheumatica showed a statistically significant, clinically meaningful difference in sustained remission rates agai","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BJT1NW94.SGD","BK4588","LU0320765489.SGD","IE0002141913.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","LU0208291251.USD","BK4585","LU0211331839.USD","IE00B4R5TH58.HKD","BK4532","LU0070302665.USD","NVS","BK4007","BK4578","IE00BFTCPJ56.SGD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640371928","title":"Celcuity Says Gedatolisib Outperforms Novartis' Alpelisib Plus Fulvestrant in Phase 3 Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2640371928","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640371928?lang=en_us&edition=fundamental","pubTime":"2026-06-03 03:09","pubTimestamp":1780427391,"startTime":"0","endTime":"0","summary":"Celcuity  said Tuesday that detailed results from the Phase 3 Viktoria-1 trial showed its investigational breast cancer treatment gedatolisib outperformed Novartis'  alpelisib plus fulvestrant in patients with hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer.Celcuity said the gedatolisib plus fulvestrant and palbociclib, or gedatolisib-triplet reduced the risk of disease progression or death by 50% compared with alpelisib plus fulvestrant, and nearly doubled median progression-free survival to 11.1 months from 5.6 months, while gedatolisib plus fulvestrant, or gedatolisib-doublet extended progression-free survival to 11.3 months, with objective response rates of 48.9% and 35.7%, respectively.The gedatolisib triplet and doublet regimens were generally well tolerated, with mostly low-grade treatment-related adverse events, while overall survival data, a key secondary endpoint, showed promising trends but remain immature. Celcuity plans to submit the data to","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0002141913.USD","BK4532","IE00B4R5TH58.HKD","BK4585","LU0070302665.USD","CELC","BK4578","IE00BFTCPJ56.SGD","BK4007","IE00BJT1NW94.SGD","NVS","LU0208291251.USD","LU0320765489.SGD","LU0211331839.USD","IE0009355771.USD","BK4588","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185803561","title":"Movement Alert｜Novartis Falls 3.06% in Regular Trading, Trading at $144.97","url":"https://stock-news.laohu8.com/highlight/detail?id=1185803561","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185803561?lang=en_us&edition=fundamental","pubTime":"2026-06-01 22:15","pubTimestamp":1780323302,"startTime":"0","endTime":"0","summary":"On June 1, Novartis fell 3.06% in regular trading, trading at $144.97/share, with trading volume of $46.1449 million.Within the Pharmacy sector where Novartis belongs, the overall sector is under...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640932143","title":"Novartis's Next Prostate Cancer Therapy Could Raise Bar for Treatment -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2640932143","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640932143?lang=en_us&edition=fundamental","pubTime":"2026-06-01 16:49","pubTimestamp":1780303740,"startTime":"0","endTime":"0","summary":"0849 GMT - Novartis is developing an experimental therapy that could raise the bar for the treatment of prostate cancer, Vontobel's Stefan Schneider says in a research note. The Swiss drugmaker released data from an early-stage clinical trial for its 225Ac-PSMA-617 drug candidate that showed so-called alpha particle radioactive isotopes should work in fighting prostate cancer, the analyst says. The new therapy differs from Novartis's approved Pluvicto prostate-cancer treatment in the radioisotope it uses to kill cancer cells, Vontobel says. Pluvicto carries a beta particle that travels for a longer range but is less lethal, while the new therapy uses an alpha particle that is more lethal but travels shorter distances, the analyst says. Deploying both could raise the bar for the treatment of prostate cancer, he adds. Shares fall 1.9%. ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","BK4578","LU0211331839.USD","BK4585","LU0320765489.SGD","IE00B4R5TH58.HKD","NVS","LU0208291251.USD","BK4532","BK4007","IE0009355771.USD","LU0070302665.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","BK4588","IE00B2B36J28.USD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640986487","title":"Novartis announces results on rPFS improvements across subgroups with Pluvicto","url":"https://stock-news.laohu8.com/highlight/detail?id=2640986487","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640986487?lang=en_us&edition=fundamental","pubTime":"2026-06-01 05:50","pubTimestamp":1780264207,"startTime":"0","endTime":"0","summary":"Novartis (NVS) announced results showing consistent radiographic progression-free survival, rPFS, improvement across key subgroups with Pluvicto pl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-announces-results-on-rpfs-improvements-across-subgroups-with-pluvicto-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-announces-results-on-rpfs-improvements-across-subgroups-with-pluvicto-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0208291251.USD","IE00BJJMRZ35.SGD","LU0320765489.SGD","BK4578","IE00BFTCPJ56.SGD","BK4007","NVS","BK4585","BK4588","BK4532","IE00BJT1NW94.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE0002141913.USD","LU0211331839.USD","LU0070302665.USD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639988884","title":"Experimental Novartis radiopharma drug shows promise in early study","url":"https://stock-news.laohu8.com/highlight/detail?id=2639988884","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639988884?lang=en_us&edition=fundamental","pubTime":"2026-05-31 19:15","pubTimestamp":1780226101,"startTime":"0","endTime":"0","summary":"Experimental Novartis radiopharma drug shows promise in early study Early data shows Novartis' experimental radiopharma drug reduces tumor markers in patients with advanced prostate cancer Novartis sa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260531:nL4N4261K8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00BJT1NW94.SGD","LU0320765489.SGD","IE00B4R5TH58.HKD","IE0009355771.USD","BK4532","NVS","IE00BFTCPJ56.SGD","LU0208291251.USD","LU0211331839.USD","BK4007","IE00BJJMRZ35.SGD","BK4588","IE00B2B36J28.USD","BK4578","IE0002141913.USD","LU0070302665.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638684413","title":"A New, Powerful Cholesterol-Lowering Drug Is on the Horizon -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2638684413","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638684413?lang=en_us&edition=fundamental","pubTime":"2026-05-28 00:00","pubTimestamp":1779897600,"startTime":"0","endTime":"0","summary":"A new class of drugs is poised to take on an insidious cause of heart attacks and strokes that has eluded treatment for decades.Amgen and Eli Lilly are also developing medicines that lower the level of lipoprotein, a fatty particle in the blood that is known as Lp. It can cause plaque to build up in blood vessels and is linked to heart disease.Tens of millions of people in the U.S. have elevated Lp, an inherited and largely hidden driver of heart disease. If Lp drugs work, companies could be on the verge of the next big heart-drug market. Citi analysts estimate it could be valued at as much as $25 billion a year worldwide.This isn't a sure bet, though. Effective Lp drugs have proven difficult to develop. In the past, scientists found drugs that lowered levels of the particle a moderate amount but failed to reduce heart attacks and strokes in research studies, leaving patients with no approved treatment.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0096364046.USD","SG9999017495.SGD","LU2361044949.HKD","LU2357305700.SGD","LU2468319806.SGD","LU1551013342.USD","LU2461242641.AUD","LU1988902786.USD","IE00B7KXQ091.USD","LU0070302665.USD","LU0203202063.USD","LU1069344957.HKD","LU2491049909.HKD","BK4581","LU2087625088.SGD","NVS","BK4533","BK4599","LU2023251221.USD","LU2237438978.USD","LU1548497426.USD","IE00BFSS7M15.SGD","AMGN","LLYZ","SG9999015978.USD","LU0823434583.USD","LU2089283258.USD","LU1127390331.HKD","LU2237443465.HKD","LU1868836914.USD","LU1551013425.SGD","LU2237443622.USD","LU2361045086.USD","LU0266013472.USD","LU1917777945.USD","LU2552382058.USD","LU2491050154.USD","LU2242652126.USD","GB00BDT5M118.USD","LU0943347566.SGD","IE00BKDWB100.SGD","LU0238689110.USD","LU0006306889.USD","LU1868836757.USD","LU0106261372.USD","SG9999013999.USD","LU0210536198.USD","LU0868494617.USD","LU1868836591.USD","LU2237443549.SGD","LU2360106947.USD","LU2552382215.SGD","ELIL","LU1720051017.SGD","IONS","IE00BFSS8Q28.SGD","04332","BK4007","LU0094547139.USD","LU0320765489.SGD","LU2028103732.USD","BK4566","LU2211815571.USD","LU1145028129.USD","LU2491050071.SGD","LU1280957306.USD","SG9999018865.SGD","LU0820562030.AUD","IE00B1XK9C88.USD","LU1366192091.USD","LU0820561818.USD","SGXZ51526630.SGD","LU0198837287.USD","LU2750360997.AUD","LU1571399168.USD","LU0122379950.USD","LU2108987350.USD","LU0354030511.USD","IE0004445015.USD","BK4585","LU2168564495.EUR","IE0004445239.USD","LU0823434740.USD","LU2462157665.USD","BK4139","LU0158827948.USD","LU1712237335.SGD","LU0882574139.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU0820561909.HKD","LU1232071149.USD","LU0786609619.USD","BK4516","LU0323591593.USD","LU0203201768.USD","SGXZ99366536.SGD","LU0316494557.USD","LU2746668461.USD","LU2106854487.HKD","IE00B2B36J28.USD","LU2089284900.SGD","LU0823416689.USD","LU2471134879.HKD","IE00BJLML261.HKD","LU2168564222.USD","IE00BWXC8680.SGD","LU2063271972.USD","LU2264538146.SGD","LU0456855351.SGD","LU2168564149.EUR","LU2237443895.HKD","LU1989771016.USD","LU0320765992.SGD","LU2750360641.GBP","SG9999014880.SGD","LU0689472784.USD","LU2168564065.EUR","LLII","LU1868837136.USD","LU0432979614.USD","SG9999014898.SGD","LU2456880835.USD","IE0001KFT4U8.USD","IE00B1BXHZ80.USD","IE0005OL40V9.USD","LU0256863902.USD","LU0289739699.SGD","LU0061475181.USD","LU2168563687.JPY","IE0009355771.USD","LU2602419157.SGD","LLYX","LU1267930730.SGD","LU0466842654.USD","LU0385154629.USD","LU0889565916.HKD","LU1061106388.HKD","IE00B4R5TH58.HKD","LU0208291251.USD","LU2265009873.SGD","LU2471134796.USD","LU0787776722.HKD","LU2089984988.USD","IE00BJJMRY28.SGD","LU0471298694.HKD","LU2023250504.SGD","LU1814569148.SGD","LU1291159041.SGD","LU2271345857.HKD","SG9999015952.SGD","LU2023250330.USD","LU2746668974.SGD","LU2324357040.USD","LU0672654240.SGD","LU1868837300.USD","LU0640476718.USD","LU1983299246.USD","LU1629891620.HKD","SG9999014914.USD","LU0320765059.SGD","SG9999015986.USD","LU2471134523.USD","SGXZ57979304.SGD","IE00BJT1NW94.SGD","LU0964807845.USD","LU0114720955.EUR","LU0256863811.USD","LU0353189680.USD","IE00BN29S564.USD","SGXZ81514606.USD","LU1323610961.USD","LU2242646821.SGD","LU0354030438.USD","IE00BK4W5L77.USD","LU2236285917.USD","IE00BJJMRX11.SGD","IE00BKPKM429.USD","LU0225283273.USD","LU0683600562.USD","LU1064131342.USD","LU1720051108.HKD","LU1804176565.USD","LU2213496289.HKD","LU2471134952.CNY","SG9999001176.USD","SG9999015945.SGD","LU2896262040.SGD","LU0353189763.USD","LU2417539215.USD","LU0097036916.USD","LU1093756168.USD","IE0002141913.USD","LLY","LU1974910355.USD","SG9999001440.SGD","LU0109394709.USD","LU2756315318.SGD","SG9999018857.SGD","BK4578","LU0133085943.USD","LU0211331839.USD","BK4534","LU0708995401.HKD","LU0109391861.USD","LU0158827781.USD","ELIS","LU0079474960.USD","LU1057294990.SGD","LU1093756325.SGD","SG9999014906.USD","SGXZ31699556.SGD","LU2552382132.HKD","LU2111349929.HKD","LU0471298777.SGD","LU1623119135.USD","SG9999001176.SGD","BK4532","LU2237443382.USD","LU1023059063.AUD","BK4588","LU0058720904.USD","LU0882574055.USD","IE00B775H168.HKD","IE00BK4W5M84.HKD","LU0417517546.SGD","LU1035775433.USD","LU2361044865.SGD","LU0234572021.USD","IE00B4JS1V06.HKD","LU2237443978.SGD","LU2112291526.USD","LU2756315664.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637169312","title":"China Commerce Ministry Says Companies Include  Eli Lilly, Sanofi,  Novartis, Merck - Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2637169312","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637169312?lang=en_us&edition=fundamental","pubTime":"2026-05-22 21:20","pubTimestamp":1779456049,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nP8N3ZZ04F:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2023250330.USD","NVS","IE00BLSP4239.USD","LU1116320737.USD","LU0965509101.SGD","SG9999017495.SGD","LU2471134952.CNY","LU0943347566.SGD","LU0964807845.USD","LU0130102774.USD","LU0070302665.USD","LU1162221912.USD","LU1814569148.SGD","SG9999014914.USD","LU0058720904.USD","LU0234572021.USD","SG9999018857.SGD","LU2023250504.SGD","LU1066051498.USD","LU1934455863.HKD","IE00BJJMRZ35.SGD","LU0289739699.SGD","LU2237443465.HKD","LU0158827781.USD","LU0203345920.USD","LU0823434583.USD","LU0823434740.USD","IE00BK4W5L77.USD","IE00B4R5TH58.HKD","SG9999001440.SGD","IE00BFSS8Q28.SGD","IE00BWXC8680.SGD","IE00B775H168.HKD","LU0006306889.USD","LU0353189763.USD","LU2106854487.HKD","LU2756315318.SGD","LU2168563687.JPY","IE00BLSP4452.SGD","LU0096364046.USD","LU1712237335.SGD","LU1929549753.HKD","LU2087625088.SGD","LU0109394709.USD","LU2168564065.EUR","IE00B7KXQ091.USD","LU1548497426.USD","IE0004445239.USD","LU2023251221.USD","SG9999015341.SGD","LU1989771016.USD","LU0965509010.AUD","LU0203201768.USD","LU1291159041.SGD","LU0266013472.USD","SG9999014906.USD","LU0672654240.SGD","LU1323610961.USD","IE00BKPKM429.USD","LLYZ","IE00BFSS7M15.SGD","LU1069347547.HKD","IE0005OL40V9.USD","IE00BK4W5M84.HKD","LU0320765646.SGD","LU1201861249.SGD","BK4533","LU0820561818.USD","LU1720051017.SGD","SGXZ51526630.SGD","LU0820561909.HKD","LU0823416689.USD","SG9999015945.SGD","IE00B1BXHZ80.USD","LU2433249047.HKD","LU1069344957.HKD","BK4534","IE00BBT3K403.USD","LU1064131342.USD","LU2471134523.USD","LU1585245621.USD","BK4532","LU0256863902.USD","LU2471134796.USD","LU0786609619.USD","LU1093756168.USD","IE00BKDWB100.SGD","LU2462157665.USD","LU2168564222.USD","LU2112291526.USD","SG9999015952.SGD","LU1057294990.SGD","LU0320765059.SGD","LU0385154629.USD","LU0265550946.USD","IE00B1XK9C88.USD","LU1037948897.HKD","LU0211331839.USD","SG9999002232.USD","LU0471298694.HKD","IE00BJLML261.HKD","LU0061475181.USD","BK4007","LU1934455194.USD","LU0648001328.SGD","LU2236285917.USD","LU0133085943.USD","LU2357627491.SGD","LU2360032135.SGD","LU1868837300.USD","LU0094547139.USD","LU2168564149.EUR","IE00B4JS1V06.HKD","LU0208291251.USD","LU1804176565.USD","ELIL","LU0689472784.USD","LU2089984988.USD","LU0708995401.HKD","LU2125154935.USD","LU2324357040.USD","LU1720051108.HKD","LU1868836914.USD","IE00BN29S564.USD","SG9999015358.SGD","LU0868494617.USD","SGXZ81514606.USD","LU2063271972.USD","MRK","LU0098860793.USD","LU2361044949.HKD","LU0980610538.SGD","LU1934455277.USD","LU1093756325.SGD","LU2111349929.HKD","SG9999014542.SGD","LU0079474960.USD","LU2552382058.USD","LU2361044865.SGD","LU1430594728.SGD","LU1917777945.USD","LU0417517546.SGD","LU0130517989.USD","LU1699723380.USD","LU2023250843.SGD","LU1868836591.USD","LLII","LU2089284900.SGD","LU2357305700.SGD","LU2491050071.SGD","IE0009355771.USD","LU0316494557.USD","LU1988902786.USD","BK4559","IE00BJJMRY28.SGD","LU0097036916.USD","IE00BN8TJ469.HKD","LU0198837287.USD","LU0965509283.SGD","LU1989772923.USD","LU0942090050.USD","SG9999013999.USD","SG9999014567.USD","SGXZ31699556.SGD","LU0882574055.USD","LU0354030438.USD","LU0861579265.USD","LU2125909247.SGD","IE00BFTCPJ56.SGD","LU0265550359.USD","LU2237443978.SGD","LU0122379950.USD","SG9999015986.USD","BK4578","LU0256863811.USD","LU0471298777.SGD","LU1066051225.USD","SG9999001176.SGD","BK4581","LU1035773651.USD","LLYX","LU1551013342.USD","LU2237443549.SGD","LU1061106388.HKD","LU2360106947.USD","SG9999002224.SGD","LU0859254822.USD","LU2237443382.USD","LU2264538146.SGD","IE00BSNM7G36.USD","LU2552382215.SGD","ELIS","LU2361045086.USD","LU2491049909.HKD","SG9999014575.USD","IE00BJJMRX11.SGD","LU2456880835.USD","LU1232071149.USD","IE00B2B36J28.USD","SG9999018865.SGD","LU0225283273.USD","LU2756315664.SGD","LU1127390331.HKD","GCVRZ","LU1280957306.USD","SG9999014880.SGD","LU1023059063.AUD","LU1623119135.USD","LU0238689110.USD","LU2108987350.USD","LU0114720955.EUR","LU1941712348.USD","IE00BJT1NW94.SGD","BK4599","LU0106261372.USD","LU1629891620.HKD","LU1868836757.USD","LU0882574139.USD","LU1983299246.USD","LU2125909593.SGD","LU2896262040.SGD","LU2213496289.HKD","LU2237443895.HKD","GB00BDT5M118.USD","LU1551013425.SGD","LU0323591593.USD","LU0203202063.USD","BK4588","LLY","LU0640476718.USD","LU2602419157.SGD","SG9999001176.USD","LU0456855351.SGD","LU2237443622.USD","LU2237438978.USD","LU1868837136.USD","IE000M9KFDE8.USD","LU2491050154.USD","LU0320765489.SGD","LU1366192091.USD","LU0683600562.USD","LU2471134879.HKD","SGXZ57979304.SGD","LU0889565916.HKD","LU1941712264.USD","LU1923622614.USD","LU2417539215.USD","IE0001KFT4U8.USD","LU2089283258.USD","IE0002141913.USD","BK4516","LU0354030511.USD","LU2265009873.SGD","LU1037948541.HKD","LU0109391861.USD","LU1145028129.USD","IE0004445015.USD","LU0868494708.USD","LU0210536198.USD","LU1989772840.SGD","LU0985320562.USD","BK4550","LU1116320901.HKD","LU2271345857.HKD","SG9999014559.SGD","LU0158827948.USD","LU1066053197.SGD","LU2211815571.USD","LU2461242641.AUD","LU0820562030.AUD","LU0787776722.HKD","BK4585","LU2028103732.USD","SG9999014898.SGD","LU0320765992.SGD","LU2750360997.AUD","LU2746668974.SGD","LU0432979614.USD","SGXZ99366536.SGD","LU1035775433.USD","LU0203347892.USD","LU1066051811.HKD","LU1974910355.USD","LU1267930730.SGD","LU2168564495.EUR","LU2552382132.HKD","LU0353189680.USD","SG9999015978.USD","LU2125154778.USD","LU1571399168.USD","LU0477156953.USD","LU0466842654.USD","LU2750360641.GBP","LU2468319806.SGD","LU0965508806.USD","LU2746668461.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636071277","title":"Big Pharma Firms Denied Certiorari by Supreme Court in Medicare Pricing Case","url":"https://stock-news.laohu8.com/highlight/detail?id=2636071277","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636071277?lang=en_us&edition=fundamental","pubTime":"2026-05-18 22:13","pubTimestamp":1779113609,"startTime":"0","endTime":"0","summary":"The US Supreme Court on Monday denied petitions for writs of certiorari filed by six big pharmaceutical companies seeking to challenge the legality of the so-called 'Drug Price Negotiation Program' under the Inflation Reduction Act of 2022.AstraZeneca , Novartis , Novo Nordisk , Johnson & Johnson's  Janssen Pharmaceuticals, Bristol Myers Squibb  and Boehringer Ingelheim Pharmaceuticals all had their petitions denied by the Supreme Court.The companies did not immediately respond to requests for comment from MT Newswires.Price: 183.25, Change: +1.67, Percent Change: +0.92","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0306806265.USD","LU1023059063.AUD","NVOX","LU0345769631.USD","IE00B42XCP33.USD","LU0689472784.USD","LU0912757837.SGD","LU1778281490.HKD","LU0426417589.USD","LU0208291251.USD","LU2756315318.SGD","IE00BLSP4239.USD","BK4578","LU1989771016.USD","LU1221951129.SGD","LU0889565916.HKD","IE000BZT7R73.USD","LU0345769128.USD","IE00BVYPNW00.USD","LU0098860793.USD","LU0096364046.USD","LU0210536198.USD","LU0053666078.USD","BMY","LU1670710588.SGD","LU0267386448.USD","LU2242652126.USD","IE00B3PB1722.GBP","LU1670711123.USD","BK4550","LU2237443978.SGD","IE00B2B36J28.USD","LU1585245621.USD","BK7104","LU1244550221.USD","LU2756315664.SGD","LU2417539215.USD","LU1732799900.SGD","LU0154236417.USD","IE00BJJMRZ35.SGD","LU1674673428.USD","LU1670710661.SGD","LU2237443549.SGD","LU2471134879.HKD","LU0882574055.USD","LU1043141123.HKD","LU0345770308.USD","LU1244550577.SGD","LU2125154935.USD","LU2456880835.USD","LU2125154778.USD","LU1196500208.SGD","LU0345770993.USD","IE00B7SZLL34.SGD","AZN","LU2468319806.SGD","LU1868836757.USD","SG9999001176.USD","BK4588","LU0456855351.SGD","LU0820562030.AUD","LU0964807845.USD","LU0225771236.USD","BK4559","IE0002270589.USD","LU0109394709.USD","IE0009355771.USD","BK4532","IE00BKVL7J92.USD","IE000WAW04H5.SGD","IE00BSNM7G36.USD","BK4007","IE00BN8TJ469.HKD","LU0795875086.SGD","IE00B1BXHZ80.USD","LU1043141396.HKD","LU0889566641.SGD","LU1291159041.SGD","NVS","LU2750360997.AUD","LU2237443382.USD","LU1929549753.HKD","LU0320765489.SGD","IE00B3T34201.USD","LU1670711040.USD","LU0868494617.USD","LU2236285917.USD","BK4504","LU1267930813.SGD","LU2237443465.HKD","LU1162221912.USD","IE0002141913.USD","LU1059921491.USD","LU1066051225.USD","LU1935042991.SGD","LU1093756168.USD","LU1894683264.USD","LU2462157665.USD","LU1145028129.USD","IE00B4R5TH58.HKD","LU2129689431.USD","LU0432979614.USD","LU1121112475.USD","BK4581","LU0994945656.USD","NVOH","LU1894683348.USD","LU2112291526.USD","LU0122379950.USD","LU1629891620.HKD","LU1732800096.USD","LU1093756325.SGD","LU0070217475.USD","LU0787776722.HKD","LU1280957306.USD","IE0001KFT4U8.USD","LU0234570918.USD","LU2023250330.USD","LU2237443895.HKD","LU0234572021.USD","LU1506573853.SGD","IE00BFXG1179.USD","LU0985481810.HKD","LU1674673691.USD","AZNH","LU0058720904.USD","LU2505996681.GBP","LU1074936037.SGD","LU0320765992.SGD","LU1829250122.USD","LU0820561909.HKD","LU0820561818.USD","BK4592","LU1221951046.USD","IE000M9KFDE8.USD","LU1430594728.SGD","LU1228905540.USD","LU0061475181.USD","IE000SO60NU8.SGD","LU0943347566.SGD","LU2129689605.HKD","IE000MB6IJN5.SGD","LU1261432733.SGD","NVO","LU2471134796.USD","LU0689626769.HKD","LU2360032135.SGD","BK4599","LU0545562505.USD","LU2430703251.USD","LU1032955483.USD","LU0792757196.USD","LU2347655156.SGD","LU2505996509.AUD","IE00BVYPNV92.GBP","SGXZ57979304.SGD","IE00BBT3K403.USD","LU1244550494.USD","LU1066051498.USD","LU0466842654.USD","LU2471134952.CNY","LU0795875169.SGD","LU2430703095.HKD","IE00BFTCPJ56.SGD","BK4533","IE00BGHQF631.EUR","IE00B19Z3581.USD","LU0237698245.USD","LU1883839398.USD","LU0114720955.EUR","LU1571399168.USD","SG9999001176.SGD","SG9999002224.SGD","LU0124676726.USD","IE00BZ1G4Q59.USD","LU1868837136.USD","LU1228905037.USD","IE0034235303.USD","LU0321505868.SGD","BK4585","IE00BLSP4452.SGD","LU0683600562.USD","LU0203347892.USD","LU1066051811.HKD","LU0640476718.USD","LU0426412945.USD","LU2430703178.SGD","LU2213496289.HKD","JNJ","LU0203345920.USD","LU1323610961.USD","IE00BJT1NW94.SGD","LU2242646821.SGD","LU1868837300.USD","LU1914381329.SGD","LU2750360641.GBP","LU0306807586.USD","LU1057294990.SGD","LU0289739699.SGD","LU1868836914.USD","LU2592432038.USD","SG9999013999.USD","LU0210528500.USD","LU2471134523.USD","LU1868836591.USD","LU1032466523.USD","LU0211331839.USD","BK4568","LU1066053197.SGD","LU2602419157.SGD","LU2129689514.USD","LU0985320562.USD","LU2403377893.USD","LU2133065610.SGD","LU1061106388.HKD","LU1718418525.SGD","LU0225284248.USD","BK4534","LU2237443622.USD","IE00B19Z3B42.SGD","LU0070302665.USD","LU1551013342.USD","LU1551013425.SGD","LU0321505439.SGD","SG9999002232.USD","SG9999001440.SGD","LU0320765646.SGD","IE000F7OJYX1.SGD","LU2896262040.SGD","IE00BDGV0183.EUR","LU1983299246.USD","LU1496350502.SGD","IE0000B7K699.USD","LU2089984988.USD","LU2487616109.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636902256","title":"Novartis Says Prostate Cancer Treatment Lowers Progression Risk By 58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636902256","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636902256?lang=en_us&edition=fundamental","pubTime":"2026-05-18 18:31","pubTimestamp":1779100268,"startTime":"0","endTime":"0","summary":"Novartis  said Sunday its Pluvicto prostate cancer medication combined with standard care lowered the risk of disease progression by 58% compared to standard care alone in a clinical trial.The combination therapy achieved deeper reductions in prostate-specific antigen levels at 12, 24, and 48 weeks, while severe adverse events occurred in 50.7% of patients receiving the regimen compared to 43% in the control group, the company said.The combination therapy achieved deep prostate-specific antigen reductions in 47.6% of patients at 12 weeks and 87.4% at 48 weeks, compared to 37.7% and 74.9%, respectively, for standard care alone, Novartis said.Regulatory submissions for the increased use have been filed in the US, China, and Japan, with initial decisions expected in H2, it added.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","IE00B2B36J28.USD","NVS","LU0211331839.USD","BK4007","LU0320765489.SGD","IE0002141913.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","LU0070302665.USD","BK4578","IE00B4R5TH58.HKD","LU0208291251.USD","BK4532","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":4,"totalSize":160,"code":"91000000","status":"200"}]}}